Bruce L. Davidson

9.5k citations

53 papers · 6.9k indexed · 7 hit papers · h-index 30

Impact in

Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.2%
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments

Papers in

Internal Medicine 43
- Venous Thromboembolism Diagnosis and Management 43
Cardiology and Cardiovascular Medicine 35
- Atrial Fibrillation Management and Outcomes 31
- Acute Myocardial Infarction Research 13
- Antiplatelet Therapy and Cardiovascular Diseases 5

Co-authors: Martin H. Prins Anthonie W.A. Lensing Scott D. Berkowitz Michael R. Lassen Alexander Gallus Vittorio Pengo Paolo Prandoni Sabino Iliceto
Journals: Journal of Thrombosis and Haemostasis (6 papers)Thrombosis and Haemostasis (5 papers)CHEST Journal (5 papers)Thrombosis Journal (2 papers)PharmacoEconomics (2 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Bruce L. Davidson

51 papers receiving 6.6k citations

Hit Papers

7 papers align trajectories log scale

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism 2017 · 492 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 New England Journal of Medicine
2016 Journal of Thrombosis and Haemostasis
2013 Thrombosis Journal
2009 The Lancet
2008 The Journal of Arthroplasty
2006 BMJ
2004 New England Journal of Medicine

Peers

Countries citing papers authored by Bruce L. Davidson

Since Specialization

Citations

This map shows the geographic impact of Bruce L. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce L. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce L. Davidson more than expected).

Fields of papers citing papers by Bruce L. Davidson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce L. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce L. Davidson. The network helps show where Bruce L. Davidson may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce L. Davidson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce L. Davidson Line = papers co-authored together Bruce L. Davidson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pulmonary embolism prophylaxis and treatment: What's right, what's wrong, and the future PubMed ·Bruce L. Davidson, Nicolas De Schryver	2025	0
2	Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin Thrombosis Research ·Paolo Prandoni, Anthonie W.A. Lensing, Martin H. Prins, Martin Gebel, Ákos F. Pap, Martin Homering, Rupert Bauersachs, Jan Beyer‐Westendorf, Henri Bounameaux, Alexander T. Cohen, Bruce L. Davidson, Bonno van Bellen, Peter Verhamme, Philip S. Wells, Žhong Yuan, Bennett Levitan, Jeffrey I. Weitz	2018	11
3	Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH Journal of Thrombosis and Haemostasis ·Karlyn A. Martin, Jan Beyer‐Westendorf, Bruce L. Davidson, Menno V. Huisman, Per Morten Sandset, Stephan Moll Hit paper breakdown →	2016	328
4	Practical Management of Anticoagulation in Patients With Atrial Fibrillation Journal of the American College of Cardiology ·Richard J. Kovacs, Greg C. Flaker, Sherry J. Saxonhouse, John Doherty, Kim K. Birtcher, Adam Cuker, Bruce L. Davidson, Robert P. Giugliano, Christopher B. Granger, Amir K. Jaffer, Bella H. Mehta, Edith A. Nutescu, Kim A. Williams	2015	69
5	Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism Thrombosis and Haemostasis ·Rupert Bauersachs, Jan Beyer‐Westendorf, Henri Bounameaux, Timothy Brighton, Alexander Cohen, Bruce L. Davidson, Gerlind Holberg, Ajay K. Kakkar, Anthonie W.A. Lensing, Martin H. Prins, Lloyd Haskell, Bonno van Bellen, Peter Verhamme, Philip Wells, Noelma Dutra da Silva, Kirsteen Duncan, (unknown)	2015	35
6	The Association of Direct Thrombin Inhibitor Anticoagulants With Cardiac Thromboses CHEST Journal ·Bruce L. Davidson	2014	15
7	Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies Thrombosis Journal ·Martin H. Prins, Anthonie WA Lensing, Rupert Bauersachs, Bonno van Bellen, Henri Bounameaux, Timothy Brighton, Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Gary E. Raskob, Scott D. Berkowitz, Philip S. Wells, (unknown) Hit paper breakdown →	2013	427
8	Effect of a public awareness campaign on the incidence of symptomatic objectively confirmed deep vein thrombosis: a controlled study Journal of Thrombosis and Haemostasis ·Witold Tomkowski, Patricia M. Albarracín, Paweł Kuca, Piotr Andziak, Arkadiusz Jawień, Damian Ziaja, X. Cai, M Górska, Bruce L. Davidson	2012	11
9	A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study BMC Complementary and Alternative Medicine ·Chiranjeev Dash, Fung‐Lung Chung, María M. Bobillo, Emily J. Greenspan, Bin Zhang, Kepher H. Makambi, Yukihiko Hara, Kenneth Newkirk, Bruce L. Davidson, Lucile L. Adams‐Campbell	2012	5
10	Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE CHEST Journal ·Theodore E. Warkentin, Bruce L. Davidson, Harry R. Büller, Alexander Gallus, Michael Gent, Anthonie W.A. Lensing, Franco Piovella, Martin H. Prins, Cui Shuli, John G. Kelton	2011	53
11	Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial Thrombosis and Haemostasis ·Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Alexander Gallus, Michael Gent, Franco Piovella, Martin H. Prins, Gary E. Raskob, Harry R. Büller, Nurlan Chanachev	2010	19
12	Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials Journal of Thrombosis and Haemostasis ·Bruce L. Davidson, Harry R. Büller, Hervé Decousus, Alexander Gallus, Michael Gent, Franco Piovella, Martin H. Prins, Gary E. Raskob, Cui Shuli, A.W.A. Lensing	2007	47
13	The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement Journal of Thrombosis and Haemostasis ·Michael R. Lassen, Bruce L. Davidson, Alexander Gallus, Graham F. Pineo, Jack Ansell, David Deitchman	2007	294
14	Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis JAMA ·Jean‐Noël Fiessinger, Menno V. Huisman, Bruce L. Davidson, Henri Bounameaux, Charles W. Francis, Henry Eriksson, Torbjörn Lundström, Scott D. Berkowitz, Per Nyström, 忠弘永井, Jeffrey S. Ginsberg, Е.В. Коненкова	2005	218
15	Early vs delayed initiation of fondaparinux prophylaxis to prevent postoperative pulmonary embolism: A clinical endpoint study CHEST Journal ·Bruce L. Davidson, A. G. G. Turpie, Clifford W. Colwell, Louis M. Kwong	2004	1
16	A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism PharmacoEconomics ·Sean D. Sullivan, Bruce L. Davidson, Susan R. Kahn, James E. Muntz, Gerry Oster, Gary E. Raskob	2004	29
17	Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study Journal of Thrombosis and Haemostasis ·Clifford W. Colwell, Scott D. Berkowitz, Bruce L. Davidson, Paul A. Lotke, Jeffrey S. Ginsberg, Jay R. Lieberman, Jacqueline Neubauer, Jennifer McElhattan, Gary Peters, C. W. Francis	2003	119
18	The Economics of Venous Thromboembolism Prophylaxis CHEST Journal ·Bruce L. Davidson, Sean D. Sullivan, Susan R. Kahn, Lars C. Borris, Kumar Pancham, Gary E. Raskob	2003	10
19	Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery PharmacoEconomics ·Sean D. Sullivan, Susan R. Kahn, Bruce L. Davidson, Lars C. Borris, Kumar Pancham, Gary E. Raskob	2003	59
20	Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty Annals of Internal Medicine ·Charles W. Francis, Bruce L. Davidson, Scott D. Berkowitz, Paul A. Lotke, Jeffrey S. Ginsberg, Jay R. Lieberman, Kyle Stroh, James P. Whipple, Gary Peters, Clifford W. Colwell	2002	47

About Bruce L. Davidson

Bruce L. Davidson is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Emergency Medical Services and Complementary and Manual Therapy, having authored 53 papers that have together received 6.9k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (43 papers), Atrial Fibrillation Management and Outcomes (31 papers), Acute Myocardial Infarction Research (13 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Central Venous Catheters and Hemodialysis (5 papers) and Acute Ischemic Stroke Management (3 papers). The work is most often cited by research in Internal Medicine (5.5k citations), Cardiology and Cardiovascular Medicine (5.2k citations), Emergency Medical Services (616 citations), Hematology (915 citations) and Surgery (1.4k citations). Bruce L. Davidson has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Martin H. Prins, Anthonie W.A. Lensing, Scott D. Berkowitz, Michael R. Lassen, Alexander Gallus, Vittorio Pengo, Paolo Prandoni, Sabino Iliceto, Alessandra Biasiolo and P Albanese. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, CHEST Journal, Thrombosis Journal and PharmacoEconomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact